You are here

“Hospital based infections of Gram negative organisms: Study Report.”

Journal Name:

Publication Year:

Abstract (2. Language): 
Introduction: The discovery of the antibiotics in 1928 revolutionized the practices of medicine. This fact raises a significant problem with respect to antimicrobial chemotherapy. The present study was planned to study the hospital based infections events of specially gram negative organisms. Study Design: The present prospective study was conducted in a large tertiary care hospital during 2007-2008. 300 serial isolates of gram negative bacteria from various clinical samples from indoor patients were included. They were from pus, sputum, blood, urine, CSF, other fluids and secretions like pleural fluid, tracheal secretion. Observations & Results: out of 1546 samples screened, 300(19.40%) of them were carbapenem resistant. Amongst the carbapenem resistant isolate obtained. Pseudomonas aeruginosa was the maximum with 53.96%. Patients admitted to ICU with MBL producing isolates had more mortality than similar patients in the ward. Also patients harboring Acinetobacter.spp showed the highest mortality in the groups (Wards & ICUs) Conclusion: From present work we may conclude that the MBLs have already established as a major resistance factor amongst gram negative organisms in our region.
FULL TEXT (PDF): 
797-800

REFERENCES

References: 

1. Christic A. Introduction. In infectious Disease : Epidemiology and Clinical Practice, Christic A (Eds)
Churchill Livengstone : 3rd edition ; 1980 : 1-3
2. Shibata N.Doi Y, Yamane K, Yagi T, Kurokawa H. Shibayama K. PCR typing of genetic deternminates
for metallo-ß-lactamases and Integrases carried by gram negative bacteria isolates in Japan, with focus
on the Class 3 Integron. Clin Microbiol Review 2003 ; 41(12) : 5407-5413
3.. Schilling O, Vogel A, Kostelecky B. Natal da luz H, Spenann D, Spath B Zinc and Iron- dependant
eytosolic metallo- ß- lactamase domain protiens exhibiting similar zinc binding affinities, independent of
an atypical glutamate at the metal binding site, Biochem. J . 2005;385:145-153.
4. Hirakata Y, Izumikawa Y, Yamaguchi T, Takemura H, Tanaka H, Yoshida R. Rapid detection and
evaluation of clinical characteristics of emerging multiple drug resistant gram negative rods carrying the
metallo- ß- lactamase gene blaIMP. Antimicrob Agents and Chemother 1998; 42(8) : 2006-2011.
5. Walsh T, Tolemann M, Poirel L, Nordmann P. Metallo- ß- lactamases : the quiet before the strom? Clin
Microbiol Review 2005 ; 18(2) : 306-325.
6. Peleg AY, Franklin C, Bell JM, Spelman DW. Dissemination of metallo- ß- lactamase gene blaIMP-4
among gram-negative pathogens in a clinical setting in Australia. Clin Infect Dis 2005; 41: 11549-11566.
7. Giakkoupi P,Xanthaki A,Kanelopoulou M, Vlahaki A, Miriagou V, Kontou S, Pappafragas E, Lada-
Malamou H.VIM-1 metallo- ß- lactamase producing Klebsiella pneumonia strains in Greek hospital. J Clin
Microbiol 2003; 41(8): 3893-3896.

Thank you for copying data from http://www.arastirmax.com